GENERIC NAME AVAILABLE AS BENZODIAZEPINES Alprazolam Generic, Xanax Chlordiazepoxide Generic, Librium Clonazepam Generic, Tranxene Clorazepate Generic, Klonopin Diazepam Generic, Valium Estazolam Generic, ProSom Flurazepam Generic, Dalmane Lorazepam Generic, Ativan Midazolam Generic, Versed Oxazepam Generic, Serax Quazepam Generic, Doral Temazepam Generic, Restoril Triazolam Generic, Halcion BENZODIAZEPINE ANTAGONIST Flumazenil Generic, Romazicon BARBITURATES Amobarbital Amytal Mephobarbital Mebaral (withdrawn) MISCELLANEOUS DRUGS Buspirone Generic, BuSpar GENERIC NAME AVAILABLE AS Pentobarbital Generic, Nembutal Sodium Phenobarbital Generic, Luminal Sodium Secobarbital Generic, Seconal Chloral hydrate Generic, Aquachloral Supprettes Eszopiclone Lunesta Hydroxyzine Generic, Atarax, Vistaril Meprobamate Generic, Equanil, Miltown Paraldehyde Generic Ramelteon Rozerem Suvorexant Belsomra Tasimelteon Hetlioz Zaleplon Sonata Zolpidem Generic, Ambien, Ambien-CR PREP AR A TIONS A V AIL ABLE
Ancoli-Israel S et al: Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med 2005;6:107.
Bateson AN: The benzodiazepine site of the GABA A receptor: An old target with new potential? Sleep Med 2004;5(Suppl 1):S9.
Chouinard G: Issues in the clinical use of benzodiazepines: Potency, withdrawal, and rebound. J Clin Psychiatry 2004;65(Suppl 5):7.
Clayton T et al: An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: Correlation with comparative models. Curr Med Chem 2007;14:2755.
Cloos JM, Ferreira V: Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry 2009;22:90.
Da Settimo F et al: GABA A/Bz receptor subtypes as targets for selective drugs. Curr Med Chem 2007;14:2680.
Davidson JR et al: A psychopharmacological treatment algorithm for generalized anxiety disorder. J Psychopharmacol 2010;24:3.
Drover DR: Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: Zaleplon, zolpidem and zopiclone. Clin Pharmacokinet 2004;43:227.
Drugs for Insomnia. Treatment Guidelines 2012;10:57.
Dubey AK et al: Suvorexant: The first orexin receptor antagonist to treat insomnia. J Pharmacol Pharmacother 2015;6:118.
Erman M et al: An efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomnia. Sleep Med 2006;7:17.
Gottesmann C: GABA mechanisms and sleep. Neuroscience 2002;111:231.
Hanson SM, Czajkowski C: Structural mechanisms underlying benzodiazepine modulation of the GABA(A) receptor. J Neurosci 2008;28:3490.